- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Neoadjuvant ipilimumab nivolumab
Total 2677 results
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, Belgium, Australia, Spain
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | BCLC Stage B Hepatocellular Carcinoma and other conditionsUnited States
-
Rampart Health, L.L.C.CompletedMetastatic Prostatic AdenocarcinomaUnited States
-
CoImmuneTerminatedAdvanced Renal Cell CarcinomaUnited States
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Brain MetastasesUnited States
-
Dana-Farber Cancer InstituteGateway for Cancer ResearchRecruitingEpithelioid Sarcoma | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Rhabdoid Tumor of the Kidney | Chordoma (Poorly Differentiated or De-differentiated) | Other INI1 Negative Tumors (With PI Approval) | Other SMARCA4-deficient Malignant Tumors (With PI Approval)United States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
National Cancer Institute (NCI)RecruitingMetastatic Solid Tumors | Treatment-Refractory CancersUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerUnited States
-
Suthee RapisuwonBristol-Myers SquibbActive, not recruitingMelanoma | Ocular MelanomaUnited States
-
European Organisation for Research and Treatment...TerminatedInoperable œsophageal CancerSpain, France
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedMucinous Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the ColonUnited States
-
National Cancer Centre, SingaporeNational University Hospital, Singapore; Johns Hopkins SingaporeTerminatedNon-Small Cell Lung CancerSingapore
-
ExcellaBio LLCTerminatedGastric Cancer | Ovarian Cancer | Breast Cancer FemaleUnited States
-
Kidney Cancer Research BureauUnknownNivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.Renal Cell CarcinomaRussian Federation
-
ERLINDA M GORDONRecruitingAdvanced Soft-tissue SarcomaUnited States
-
Brown UniversityBristol-Myers SquibbRecruitingNon Small Cell Lung CancerUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalActive, not recruitingMelanomaUnited States
-
Asylia Diagnostics BVRecruiting
-
Hackensack Meridian HealthTerminatedLymphoma | Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Greg Durm, MDBristol-Myers Squibb; Big Ten Cancer Research ConsortiumActive, not recruitingNon-small Cell Lung CancerUnited States
-
Hatim HusainActive, not recruitingAdvanced NSCLCUnited States
-
Bristol-Myers SquibbCompletedHead and Neck CancerUnited States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
-
Dana-Farber Cancer InstituteBristol-Myers SquibbSuspendedNon-small Cell Lung CancerUnited States
-
Sarah Sammons, MDBristol-Myers Squibb; Duke UniversityTerminated
-
Bristol-Myers SquibbWithdrawnMelanomaFrance, Italy, Poland, United States, Brazil, Spain, Australia, Denmark, Germany, Austria, Netherlands, Russian Federation, Belgium, United Kingdom, Sweden, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell Myeloma | Myeloproliferative Neoplasm | Recurrent... and other conditionsUnited States
-
Washington University School of MedicineBristol-Myers Squibb; ExelixisActive, not recruitingMetastatic Soft-tissue SarcomaUnited States
-
Toni Choueiri, MDBristol-Myers SquibbActive, not recruitingRenal CancerUnited States
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingGastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Neuroendocrine TumoursAustralia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedLung CancerAustralia, China, Romania, Colombia, Ireland, Israel, Japan, Spain, Peru, United States, Brazil, Greece, Singapore, Argentina, Austria, Belgium, Canada, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Mexico, Netherlands, ... and more
-
University of ChicagoTerminatedHepatocellular CarcinomaUnited States
-
Jiangsu Cancer Institute & HospitalRecruitingLocally Advanced Esophageal CarcinomaChina
-
Spanish Oncology Genito-Urinary GroupBristol-Myers SquibbRecruiting
-
National University Hospital, SingaporeBristol-Myers Squibb; OncoTherapy Science, Inc.Recruiting
-
Yale UniversityApexigen America, Inc.Active, not recruitingRenal Cell Carcinoma | Advanced MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruiting
-
Fox Chase Cancer CenterIncuronSuspendedLocally Advanced or Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingAdrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Massachusetts General HospitalBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedRenal Cell CarcinomaUnited States, Australia, Chile
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Intergroupe Francophone de Cancerologie Thoracique; Frontier... and other collaboratorsUnknownSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerSwitzerland, France, Spain, Germany, United Kingdom, Netherlands, Australia, Belgium
-
University Hospital TuebingenTerminatedMetastatic Melanoma | Brain MetastasesGermany
-
Massachusetts General HospitalWilliam M. Wood FoundationRecruiting